Congenital dyserythropoietic anemia type I with bone abnormalities, mutations of the CDAN I gene, and significant responsiveness to alpha-interferon therapy

被引:17
作者
Goede, Jeroen S.
Benz, Rudolf
Fehr, Joerg
Schwarz, Klaus
Heimpel, Hermann
机构
[1] City Hosp Triemli, Inst Oncol & Haematol, CH-8063 Zurich, Switzerland
[2] Univ Hosp Zurich, Clin Haematol, Zurich, Switzerland
[3] Univ Hosp Ulm, Dept Transfus Med, Ulm, Germany
[4] Univ Hosp Ulm, Dept Internal Med 3, Ulm, Germany
关键词
CDA I; dysostosis; interferon; skeleton;
D O I
10.1007/s00277-006-0143-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Congenital dyserythropoietic anemia type I (CDA 1) is a rare autosomal recessive disorder with ineffective erythropoiesis, characteristic morphological abnormalities of erythroblasts, and iron overloading. CDA I is caused by mutations in the CDAN I gene, encoding a protein named codanin-1. Complex bone abnormalities, especially syndactyly, have not been systematically described with this disease. We present two cases of morphologically and genetically confirmed CDA I with striking bone abnormalities and response to treatment with alpha-interferon. Our cases clearly document the association of skeletal anomalism with CDA I and indicate that codanin-1 may play a role in the development of the skeleton.
引用
收藏
页码:591 / 595
页数:5
相关论文
共 19 条
  • [1] 2 CASES OF CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE-I ASSOCIATED WITH UNUSUAL SKELETAL ABNORMALITIES OF THE LIMBS
    BRICHARD, B
    VERMYLEN, C
    SCHEIFF, JM
    MICHAUX, JL
    NINANE, J
    CORNU, G
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1994, 86 (01) : 201 - 202
  • [2] The congenital dyserythropoietic anaemias
    Delaunay, J
    Iolascon, A
    [J]. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 1999, 12 (04) : 691 - 705
  • [3] Delaunay Jean, 2003, Hematol J, V4, P225, DOI 10.1038/sj.thj.6200255
  • [4] Congenital dyserythropoietic anemia type I is caused by mutations in codanin-1
    Dgany, O
    Avidan, N
    Delaunay, J
    Krasnov, T
    Shalmon, L
    Shalev, H
    Eidelitz-Markus, T
    Kapelushnik, J
    Cattan, D
    Pariente, A
    Tulliez, M
    Crétien, A
    Schischmanoff, PO
    Iolascon, A
    Fibach, E
    Koren, A
    Rössler, J
    Le Merrer, M
    Yaniv, I
    Zaizov, R
    Ben-Asher, E
    Olender, T
    Lancet, D
    Beckmann, JS
    Tamary, H
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (06) : 1467 - 1474
  • [5] Congenital dyserythropoietic anemia type I (CDA I):: molecular genetics, clinical appearance, and prognosis based on long-term observation
    Heimpel, H
    Schwarz, K
    Ebnöther, M
    Goede, JS
    Heydrich, D
    Kamp, T
    Plaumann, L
    Rath, B
    Roessler, J
    Schildknecht, O
    Schmid, M
    Wuillemin, W
    Einsiedler, B
    Leichtle, R
    Tamary, H
    Kohne, E
    [J]. BLOOD, 2006, 107 (01) : 334 - 340
  • [6] Congenital dyserythropoietic anemias: epidemiology, clinical significance, and progress in understanding their pathogenesis
    Heimpel, H
    [J]. ANNALS OF HEMATOLOGY, 2004, 83 (10) : 613 - 621
  • [7] HOLMBERG L, 1978, SCAND J HAEMATOL, V21, P72
  • [8] Long-term alpha interferon treatment is effective on anaemia and significantly reduces iron overload in congenital dyserythropoiesis type I
    Lavabre-Bertrand, T
    Ramos, J
    Delfour, C
    Henry, L
    Guiraud, I
    Carillo, S
    Wagner, A
    Bureau, JP
    Blanc, P
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2004, 73 (05) : 380 - 383
  • [9] ACRAL DYSOSTOSIS DYSERYTHROPOIESIS SYNDROME
    LEMERRER, M
    GIROT, R
    PARENT, P
    CORMIERDAIRE, V
    MAROTEAUX, P
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 1995, 154 (05) : 384 - 388
  • [10] Interferon therapy in congenital dyserythropoietic anemia type I/II
    Marwaha, RK
    Bansal, D
    Trehan, A
    Garewal, G
    [J]. PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2005, 22 (02) : 133 - 138